Associations of vitamin D levels and clinical parameters with COVID ‐19 infection, severity and mortality in hemodialysis patients: A cohort study
Hemodialysis International · 2025
DOI: 10.1111/hdi.13194 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Hemodialysis International, 2025. Verfasst von Yanhua You und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, West China Xiamen Hospital of Sichuan University, Xiamen, China. Hauptthemen laut MEDLINE: COVID-19, Renal Dialysis, Vitamin D Deficiency, Vitamin D. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Introduction
Vitamin D deficiency is prevalent among patients undergoing hemodialysis. This study aimed to investigate the associations between vitamin D levels and clinical parameters with the risk of COVID‐19 infection, severity, and mortality in hemodialysis patients with end‐stage kidney disease (ESKD).
Methods
This retrospective cohort study included 198 hemodialysis patients from a single center. Vitamin D deficiency was defined by the last measurement of 25‐hydroxycholecalciferol less than 20 ng/mL. Vitamin D deficiency and vitamin D supplements were combined to categorize patients into three groups: deficiency, uncertain deficiency, and likely sufficient. COVID‐19 infection status, severity, and outcomes were recorded. Statistical analyses were performed to assess the associations between vitamin D levels and COVID‐19 severity and mortality.
Findings
Among the 198 patients, 73 patients (37%) were in the deficiency group, 29 patients (15%) had uncertain deficiency, and 96 patients (48%) were likely sufficient. The overall COVID‐19 infection rate was 59%. The deficiency group had a similar infection rate (60.3%) compared to those with likely sufficient levels (54.2%). However, the severity and mortality rates of vitamin D deficiency group had a significantly higher rate than those with likely sufficient levels. Multivariate logistic regression analysis showed that vitamin D deficiency and uncertain deficiency group were significantly associated with an increased risk of COVID‐19 severity (OR = 22.57, p = 0.01 and OR = 15.8, p = 0.03, respectively). Uncertain deficiency group was significantly associated with an increased risk of COVID‐19 mortality (OR = 12.93, p = 0.04), while the deficiency group should similarly trend but did not reach statistical significance.
Discussion
Vitamin D deficiency is associated with an increased risk of COVID‐19 severity in hemodialysis patients with ESKD. These findings suggest that monitoring and managing vitamin D levels may be important in reducing the risk of COVID‐19 severity in this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, West China Xiamen Hospital of Sichuan University, Xiamen, China.
- Department of Nephrology, Army 73rd Group Military Hospital, Xiamen, China.
ORCID-Profile: Yanhua You
Zitieren
APA
You, Y., Xu, C., Hu, Y., Liang, M., & Sun, Q. (2025). Associations of vitamin D levels and clinical parameters with COVID ‐19 infection, severity and mortality in hemodialysis patients: A cohort study. Hemodialysis International. https://doi.org/10.1111/hdi.13194
Vancouver
You Y, Xu C, Hu Y, Liang M, Sun Q. Associations of vitamin D levels and clinical parameters with COVID ‐19 infection, severity and mortality in hemodialysis patients: A cohort study. Hemodialysis International. 2025. doi:10.1111/hdi.13194
BibTeX
@article{You2025,
author = {You, Yanhua and Xu, Chun and Hu, Yuqing and Liang, Meng and Sun, Qi},
title = {Associations of vitamin D levels and clinical parameters with COVID ‐19 infection, severity and mortality in hemodialysis patients: A cohort study},
journal = {Hemodialysis International},
year = {2025},
doi = {10.1111/hdi.13194}
}
EUVIMED